“…6 CF also has a considerable impact in the public health systems; consequently, prevention from disease through carrier identification, genetic counseling, and prenatal diagnosis remains the most realistic approach to reduce its burden. 7 Prenatal diagnosis is recommended to the couples known to be CFTR mutation carriers and in cases of ultrasound fetal anomalies such as meconium peritonitis, hyperechogenic and/or bowel dilatation, intraabdominal calcifications and meconium ileus (MI). 7 Intestinal affection is usually the first manifestation, sometimes in the prenatal period.…”